2003•Linchuang pifuke zazhiRequires access

Efficacy of Narrow-Band UVB Phototherapy in Vitiligo Patients

Jung-Hun Park, Hyunjin Kim, Mu‐Hyoung Lee

Open publisher page 1 citations

Abstract

Background : The treatment of vitiligo requires several months of treatment and often results in disappointing outcomes. Recently, narrow band UVB phototherapy has been reported to be an effective and safe therapeutic option in patients with vitiligo. Objective : We attempted to evaluate the clinical efficacy and safety of narrow band UVB phototherapy in vitiligo patients. Methods : In an open trial, thirteen vitiligo patients were treated twice weekly with narrow band UVB phototherapy for at least six months. The degree of repigmentation was divided into 4 categories (below 25%, 26-50%, 51-75%, and above 75%). The disease activity by history was scored by means of the “vitiligo disease activity score (VIDA score)” before and 12 months after therapy. Results : In the majority of the patients(85%), more than 25% repigmentation was observed. More than 75% repigmentation was seen in 7 patients(54%). The disease activity, as represented by VIDA scores, was significantly decreased after narrow band UVB therapy(P

About this research paper

What this paper is about

Background : The treatment of vitiligo requires several months of treatment and often results in disappointing outcomes. Recently, narrow band UVB phototherapy has been reported to be an effective and safe therapeutic option in patients with vitiligo. Objective : We attempted to evaluate the clinical efficacy and safety of narrow band UVB phototherapy in vitiligo patients. Methods : In an open trial, thirteen vitiligo patients were treated twice weekly with narrow band UVB phototherapy for at least six months. The degree of repigmentation was divided into 4 categories (below 25%, 26-50%, 51-75%, and above 75%). The disease activity by history was scored by means of the “vitiligo disease activity score (VIDA score)” before and 12 months after therapy. Results : In the majority of the patients(85%), more than 25% repigmentation was observed. More than 75% repigmentation was seen in 7 patients(54%). The disease activity, as represented by VIDA scores, was significantly decreased after narrow band UVB therapy(P

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background : The treatment of vitiligo requires several months of treatment and often results in disappointing outcomes. Recently, narrow band UVB phototherapy has been reported to be an effective and safe therapeutic option in patients with vitiligo. Objective : We attempted to evaluate the clinical efficacy and safety of narrow band UVB phototherapy in vitiligo patients. Methods : In an open trial, thirteen vitiligo patients were treated twice weekly with narrow band UVB phototherapy for at least six months. The degree of repigmentation was divided into 4 categories (below 25%, 26-50%, 51-75%, and above 75%). The disease activity by history was scored by means of the “vitiligo disease activity score (VIDA score)” before and 12 months after therapy. Results : In the majority of the patients(85%), more than 25% repigmentation was observed. More than 75% repigmentation was seen in 7 patients(54%). The disease activity, as represented by VIDA scores, was significantly decreased after narrow band UVB therapy(P

Key concepts: Vitiligo, Medicine, Dermatology, Ultraviolet therapy, Disease, Internal medicine, Psoriasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of Narrow-Band UVB Phototherapy in Vitiligo Patients — Research Paper | ScholarLens